In conclusion, we propose a model for lipotoxicity-driven NAFLD-to-NASH transitions whereby lipid-laden hepatocytes secrete IL11 leading to autocrine hepatocyte metabolic dysfunction and cell death along with paracrine activation of neighbouring HSCs and other cells (Fig. 7). Here, IL11 is linked to metabolic dysfunction-associated steatotic liver disease.